Sign in

CIK 0001528115

  • Non-accelerated filer
  • Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275414423
Phone
+1 650-822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,810 shares at $5.54 ($10,027)
  2. 4/A Planned sale EVP & Chief Innovation Officer sold 22,057 shares at an average $4.49 ($99,021)
  3. 4 Open-market sale EVP & Chief Business Officer sold 978 shares at $3.84 ($3,752)
  4. 4 Open-market sale EVP & Chief Financial Officer sold 1,057 shares at $3.84 ($4,055)
  5. 4 Planned sale EVP & Chief Innovation Officer sold 21,000 shares at $4.52 ($94,966)
  6. 4 Open-market buy Director bought 350,000 shares at $2.88 ($1,008,000)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy 10% owner bought 300,000 shares at $2.13 ($639,720)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award EVP & Chief Business Officer acquired 18,975 shares (grant or award)
  20. 4 Grant or award EVP & Chief Financial Officer acquired 18,975 shares (grant or award)

Page 6 of 11 · 206 filings